Celltrion
068270.KS
#793
Rank
ยฃ18.45 B
Marketcap
ยฃ84.76
Share price
0.00%
Change (1 day)
-15.00%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): ยฃ2.48

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ2.26. In 2022 the company made an earnings per share (EPS) of ยฃ2.20 a decrease over its 2021 EPS that were of ยฃ2.62.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ2.4812.69%
2022ยฃ2.20-15.84%
2021ยฃ2.6212.77%
2020ยฃ2.3270.79%
2019ยฃ1.3615.63%
2018ยฃ1.18-33.13%
2017ยฃ1.76141.17%
2016ยฃ0.738.28%
2015ยฃ0.6711.28%
2014ยฃ0.6116.37%
2013ยฃ0.52-67.42%
2012ยฃ1.6084.22%
2011ยฃ0.8762.13%
2010ยฃ0.5380.61%
2009ยฃ0.30-559.63%
2008-ยฃ0.06438-123.16%
2007ยฃ0.28